Cue Biopharma, Inc. announced that On April 11, 2023, Patrick Verheyen was appointed to the board of directors of the company, following the recommendation of the Corporate Governance and Nominating Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +6.10% | -9.14% | -34.09% |
May. 09 | Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.09% | 79.78M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Cue Biopharma, Inc. Announces Appointment of Patrick Verheyen to Its Board of Directors